市場調査レポート

商品コード

1719444

網膜用薬の世界市場 2025～2029年

Global Retinal Drugs Market 2025-2029

出版日: 2025年04月24日
発行: TechNavio
ページ情報: 英文 217 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 364,075円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 582,520円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.63円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

網膜用薬市場は2024-2029年に94億3,490万米ドル、予測期間中のCAGRは7.1％で成長すると予測されます。

当レポートでは、網膜用薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、網膜疾患の有病率の上昇、高度診断ツールの出現、患者支援プログラムなどが牽引しています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比2025年	6.5%
CAGR	7.1%
増分額	94億3,490万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の網膜用薬市場の成長を促進する主な要因の一つとして、革新的な治療法の開発を挙げています。また、徐放性眼科用製剤の需要の増加や診断技術の進歩は、市場の大きな需要につながります。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2024-2029
欧州：市場規模と予測 2024-2029
アジア：市場規模と予測 2024-2029
世界のその他の地域：市場規模と予測 2024-2029
米国：市場規模と予測 2024-2029
ドイツ：市場規模と予測 2024-2029
カナダ：市場規模と予測 2024-2029
中国：市場規模と予測 2024-2029
英国：市場規模と予測 2024-2029
フランス：市場規模と予測 2024-2029
日本：市場規模と予測 2024-2029
イタリア：市場規模と予測 2024-2029
インド：市場規模と予測 2024-2029
韓国：市場規模と予測 2024-2029
市場機会：地域情勢別

第13章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第14章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第15章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
AbbVie Inc.
Alcon Inc.
Alimera Sciences Inc.
Bausch Health Companies Inc.
Bayer AG
Bristol Myers Squibb Co.
F. Hoffmann La Roche Ltd.
Johnson and Johnson Services Inc.
MeiraGTx Holdings Plc.
Novartis AG
Ocular Therapeutix Inc
Oxurion N
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi SA

第16章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Retinal Drugs Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Indication Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits39: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Distribution Channel
Exhibits41: Data Table on Comparison by Distribution Channel
Exhibits42: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by Distribution Channel ($ million)
Exhibits55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits56: Chart on Indication - Market share 2024-2029 (%)
Exhibits57: Data Table on Indication - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Indication
Exhibits59: Data Table on Comparison by Indication
Exhibits60: Chart on Macular degeneration - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Macular degeneration - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Macular degeneration - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Macular degeneration - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Diabetic eye disease - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Diabetic eye disease - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Diabetic eye disease - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Diabetic eye disease - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits72: Market opportunity by Indication ($ million)
Exhibits73: Data Table on Market opportunity by Indication ($ million)
Exhibits74: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits75: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits76: Chart on Comparison by Drug Class
Exhibits77: Data Table on Comparison by Drug Class
Exhibits78: Chart on VEGF-A antagonist - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on VEGF-A antagonist - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on VEGF-A antagonist - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on VEGF-A antagonist - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on TNF-A inhibitor - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on TNF-A inhibitor - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on TNF-A inhibitor - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on TNF-A inhibitor - Year-over-year growth 2024-2029 (%)
Exhibits86: Market opportunity by Drug Class ($ million)
Exhibits87: Data Table on Market opportunity by Drug Class ($ million)
Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits91: Chart on Geographic comparison
Exhibits92: Data Table on Geographic comparison
Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits149: Market opportunity By Geographical Landscape ($ million)
Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits151: Impact of drivers and challenges in 2024 and 2029
Exhibits152: Overview on criticality of inputs and factors of differentiation
Exhibits153: Overview on factors of disruption
Exhibits154: Impact of key risks on business
Exhibits155: Companies covered
Exhibits156: Company ranking index
Exhibits157: Matrix on companies position and classification
Exhibits158: AbbVie Inc. - Overview
Exhibits159: AbbVie Inc. - Product / Service
Exhibits160: AbbVie Inc. - Key news
Exhibits161: AbbVie Inc. - Key offerings
Exhibits162: SWOT
Exhibits163: Alcon Inc. - Overview
Exhibits164: Alcon Inc. - Business segments
Exhibits165: Alcon Inc. - Key news
Exhibits166: Alcon Inc. - Key offerings
Exhibits167: Alcon Inc. - Segment focus
Exhibits168: SWOT
Exhibits169: Alimera Sciences Inc. - Overview
Exhibits170: Alimera Sciences Inc. - Product / Service
Exhibits171: Alimera Sciences Inc. - Key offerings
Exhibits172: SWOT
Exhibits173: Bausch Health Companies Inc. - Overview
Exhibits174: Bausch Health Companies Inc. - Business segments
Exhibits175: Bausch Health Companies Inc. - Key news
Exhibits176: Bausch Health Companies Inc. - Key offerings
Exhibits177: Bausch Health Companies Inc. - Segment focus
Exhibits178: SWOT
Exhibits179: Bayer AG - Overview
Exhibits180: Bayer AG - Business segments
Exhibits181: Bayer AG - Key news
Exhibits182: Bayer AG - Key offerings
Exhibits183: Bayer AG - Segment focus
Exhibits184: SWOT
Exhibits185: Bristol Myers Squibb Co. - Overview
Exhibits186: Bristol Myers Squibb Co. - Product / Service
Exhibits187: Bristol Myers Squibb Co. - Key news
Exhibits188: Bristol Myers Squibb Co. - Key offerings
Exhibits189: SWOT
Exhibits190: F. Hoffmann La Roche Ltd. - Overview
Exhibits191: F. Hoffmann La Roche Ltd. - Business segments
Exhibits192: F. Hoffmann La Roche Ltd. - Key news
Exhibits193: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits194: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits195: SWOT
Exhibits196: Johnson and Johnson Services Inc. - Overview
Exhibits197: Johnson and Johnson Services Inc. - Business segments
Exhibits198: Johnson and Johnson Services Inc. - Key news
Exhibits199: Johnson and Johnson Services Inc. - Key offerings
Exhibits200: Johnson and Johnson Services Inc. - Segment focus
Exhibits201: SWOT
Exhibits202: MeiraGTx Holdings Plc. - Overview
Exhibits203: MeiraGTx Holdings Plc. - Product / Service
Exhibits204: MeiraGTx Holdings Plc. - Key offerings
Exhibits205: SWOT
Exhibits206: Novartis AG - Overview
Exhibits207: Novartis AG - Business segments
Exhibits208: Novartis AG - Key news
Exhibits209: Novartis AG - Key offerings
Exhibits210: Novartis AG - Segment focus
Exhibits211: SWOT
Exhibits212: Ocular Therapeutix Inc - Overview
Exhibits213: Ocular Therapeutix Inc - Product / Service
Exhibits214: Ocular Therapeutix Inc - Key offerings
Exhibits215: SWOT
Exhibits216: Oxurion N - Overview
Exhibits217: Oxurion N - Product / Service
Exhibits218: Oxurion N - Key offerings
Exhibits219: SWOT
Exhibits220: Pfizer Inc. - Overview
Exhibits221: Pfizer Inc. - Product / Service
Exhibits222: Pfizer Inc. - Key news
Exhibits223: Pfizer Inc. - Key offerings
Exhibits224: SWOT
Exhibits225: Regeneron Pharmaceuticals Inc. - Overview
Exhibits226: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits227: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits228: SWOT
Exhibits229: Sanofi SA - Overview
Exhibits230: Sanofi SA - Business segments
Exhibits231: Sanofi SA - Key news
Exhibits232: Sanofi SA - Key offerings
Exhibits233: Sanofi SA - Segment focus
Exhibits234: SWOT
Exhibits235: Inclusions checklist
Exhibits236: Exclusions checklist
Exhibits237: Currency conversion rates for US$
Exhibits238: Research methodology
Exhibits239: Information sources
Exhibits240: Data validation
Exhibits241: Validation techniques employed for market sizing
Exhibits242: Data synthesis
Exhibits243: 360 degree market analysis
Exhibits244: List of abbreviations

Product Code: IRTNTR70326

The retinal drugs market is forecasted to grow by USD 9434.9 mn during 2024-2029, accelerating at a CAGR of 7.1% during the forecast period. The report on the retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in prevalence of retinal diseases, emergence of advanced diagnostic tools, and patient assistance programs.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.5%
CAGR	7.1%
Incremental Value	$9434.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's retinal drugs market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Indication

Macular degeneration
Diabetic eye disease
Others

By Drug Class

VEGF-A antagonist
TNF-A inhibitor

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of innovative therapies as one of the prime reasons driving the retinal drugs market growth during the next few years. Also, rise in demand for sustained-release ocular formulations and advances in diagnostic techniques will lead to sizable demand in the market.

The report on the retinal drugs market covers the following areas:

Retinal Drugs Market sizing
Retinal Drugs Market forecast
Retinal Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading retinal drugs market vendors that include AbbVie Inc., Alcon Inc., Alimera Sciences Inc., Bausch Health Companies Inc., Bayer AG, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Kubota Corp., MeiraGTx Holdings Plc., Novartis AG, Ocular Therapeutix Inc, Oxurion N, Pfizer Inc., Regeneron Pharmaceuticals Inc., REGENXBIO Inc, Sanofi SA, Santen Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Visufarma. Also, the retinal drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Retinal Drugs Market 2019 - 2023
- Historic Market Size - Data Table on Global Retinal Drugs Market 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Indication segment analysis 2019 - 2023
- Historic Market Size - Indication Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on global retinal drugs market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

8.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
8.3 Hospital pharmacy - Market size and forecast 2024-2029
- Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
8.4 Retail pharmacy - Market size and forecast 2024-2029
- Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
8.5 Online pharmacy - Market size and forecast 2024-2029
- Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Indication

9.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)
9.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
9.3 Macular degeneration - Market size and forecast 2024-2029
- Chart on Macular degeneration - Market size and forecast 2024-2029 ($ million)
- Data Table on Macular degeneration - Market size and forecast 2024-2029 ($ million)
- Chart on Macular degeneration - Year-over-year growth 2024-2029 (%)
- Data Table on Macular degeneration - Year-over-year growth 2024-2029 (%)
9.4 Diabetic eye disease - Market size and forecast 2024-2029
- Chart on Diabetic eye disease - Market size and forecast 2024-2029 ($ million)
- Data Table on Diabetic eye disease - Market size and forecast 2024-2029 ($ million)
- Chart on Diabetic eye disease - Year-over-year growth 2024-2029 (%)
- Data Table on Diabetic eye disease - Year-over-year growth 2024-2029 (%)
9.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)

10 Market Segmentation by Drug Class

10.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
10.3 VEGF-A antagonist - Market size and forecast 2024-2029
- Chart on VEGF-A antagonist - Market size and forecast 2024-2029 ($ million)
- Data Table on VEGF-A antagonist - Market size and forecast 2024-2029 ($ million)
- Chart on VEGF-A antagonist - Year-over-year growth 2024-2029 (%)
- Data Table on VEGF-A antagonist - Year-over-year growth 2024-2029 (%)
10.4 TNF-A inhibitor - Market size and forecast 2024-2029
- Chart on TNF-A inhibitor - Market size and forecast 2024-2029 ($ million)
- Data Table on TNF-A inhibitor - Market size and forecast 2024-2029 ($ million)
- Chart on TNF-A inhibitor - Year-over-year growth 2024-2029 (%)
- Data Table on TNF-A inhibitor - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Alcon Inc.
- Alcon Inc. - Overview
- Alcon Inc. - Business segments
- Alcon Inc. - Key news
- Alcon Inc. - Key offerings
- Alcon Inc. - Segment focus
- SWOT
15.6 Alimera Sciences Inc.
- Alimera Sciences Inc. - Overview
- Alimera Sciences Inc. - Product / Service
- Alimera Sciences Inc. - Key offerings
- SWOT
15.7 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
15.8 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.9 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.11 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.12 MeiraGTx Holdings Plc.
- MeiraGTx Holdings Plc. - Overview
- MeiraGTx Holdings Plc. - Product / Service
- MeiraGTx Holdings Plc. - Key offerings
- SWOT
15.13 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.14 Ocular Therapeutix Inc
- Ocular Therapeutix Inc - Overview
- Ocular Therapeutix Inc - Product / Service
- Ocular Therapeutix Inc - Key offerings
- SWOT
15.15 Oxurion N
- Oxurion N - Overview
- Oxurion N - Product / Service
- Oxurion N - Key offerings
- SWOT
15.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.17 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
15.18 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

網膜用薬の世界市場 2025～2029年

Global Retinal Drugs Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：流通チャネル別

第9章市場セグメンテーション：適応症別

第10章市場セグメンテーション：薬剤クラス別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Distribution Channel

9 Market Segmentation by Indication

10 Market Segmentation by Drug Class

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

網膜用薬の世界市場 2025～2029年

Global Retinal Drugs Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：流通チャネル別

第9章 市場セグメンテーション：適応症別

第10章 市場セグメンテーション：薬剤クラス別

第11章 顧客情勢

第12章 地域別情勢

第13章 促進要因・課題・機会・抑制要因

第14章 競合情勢

第15章 競合分析

第16章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Distribution Channel

9 Market Segmentation by Indication

10 Market Segmentation by Drug Class

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：流通チャネル別

第9章市場セグメンテーション：適応症別

第10章市場セグメンテーション：薬剤クラス別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録